Years Later, MS Drug Ownership Consolidation — M&A Next?
Biogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes "better late than never." The biotech and drug company is the ...Read Full Story »
Posts related to ‘multiple sclerosis’
Read Full Story »
Opexa Gets on the Map with Huge MS Pact
Opexa Therapeutics Inc. (NASDAQ: OPXA) is not just soaring this Tuesday. It is rising exponentially after securing an option and license agreement with Merck Serono on its multiple sclerosis treatment. ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9970)
- Accounting (512)
- Active Trader (4413)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5084)
- Autos (1477)
- Banking & Finance (3795)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1997)
- Dividends & Buybacks (929)
- Earnings (4153)
- Economy (3709)
- Editor's Picks (516)
- ETFs & Mutual Funds (825)
- General (3837)
- Healthcare (1435)
- Housing (1042)
- Industrials (632)
- Infrastructure (605)
- International Markets (4178)
- Internet (2196)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (657)
- Media (4206)
- Mergers & Acquisitions (2228)
- Oil & Gas (2578)
- Personal Finance (308)
- Politics (825)
- Polls (34)
- Regulation (1164)
- Retail (2587)
- Rumors (1093)
- Services (299)
- Special Report (377)
- Technology (3828)
- Telecom & Wireless (1693)
- Transportation (581)
- Value Investing (766)
